secwatch.observer — SEC 8-K summary
======================================

Issuer:     GRI Bio, Inc. (GRI)
CIK:        0001824293
Form:       8-K
Filed at:   2024-02-02T23:59:59+00:00
Accession:  0001628280-24-003067
Event type: other_material
Sentiment:  negative
Materiality: 0.75
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

GRI Bio prices $5.5M public offering of common stock and warrants at $1.10/unit
-------------------------------------------------------------------------------

- Priced offering of 5,000,000 shares (or pre-funded warrants) at $1.10 per share, raising $5.5M gross proceeds.
- Issued Series B-1 warrants (5-yr, $1.10 exercise) and Series B-2 warrants (18-mo, $1.10) for up to 10M additional shares.
- Closing expected February 6, 2024; proceeds for working capital and general corporate purposes.
- A.G.P./Alliance Global Partners acted as sole placement agent with 7% fee plus expense allowance.
- Lock-up agreements from officers and directors for 90 days post-closing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1824293/000162828024003067/0001628280-24-003067-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1824293/000162828024003067/val-20240201.htm
  HTML page:      https://secwatch.observer/filing/0001628280-24-003067

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer